SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-000850
Filing Date
2024-03-01
Accepted
2024-03-01 19:15:44
Documents
1
Period of Report
2024-02-28

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6898
  Complete submission text file 0000905148-24-000850.txt   8351
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Santos David A (Reporting) CIK: 0001820066 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 24712311